Similar content being viewed by others Introduction/background Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs) are a class of medications increasingly utilized in the treatment of type 2 diabetes and, more recently, obesity (Nathan et al
[64], which involved a co-culture of primary astrocytes with the bEnd.3 endothelial cell line, incubation with exendin-4 reduced the levels of the astrocyte-derived vascular endothelial growth factor (VEGF-A), matrix metalloproteinase-9 (MMP-9), chemokine monocyte chemoattractant protein-1 (MCP-1), and the chemokine C-X-C motif ligand 1 (CXCL-1), induced by oxygenglucose deprivation (OGD), and subsequently led to the increased expression of tight junction proteins in the bEnd.3 cells
Swethas Cosmoderm Centre, a skin clinic in Indiranagar, Bangalore, we take a nuanced position on glutathione
Abstract Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are peptide hormones and growth factors
She's Awesome